Drug intelligence / Profile preview

Albuzest

Development stage
Unknown
Lead developer
Alniche Life Sciences
Modality
Recombinant Proteins and Enzymes, Small Molecules, Peptides
Administration
Oral
01

Overview

Albuzest is a high-protein nutritional supplement developed and marketed by Alniche Life Sciences, primarily composed of egg white (albumen) powder. It is specifically formulated to address protein deficiency in patients recovering from critical illness, surgery, or chronic infections. The product features a high-protein, low-fat profile with high bioavailability compared to other protein sources like whey, soy, or casein. In addition to egg albumen, Albuzest contains a blend of essential amino acids, including branched-chain amino acids (L-Leucine, L-Isoleucine, and L-Valine), as well as L-Glutamine, L-Arginine, Taurine, and Alpha-Lipoic acid. It is further fortified with a comprehensive mix of multivitamins and minerals. Specialized variants are available for specific clinical needs, such as Albuzest-Reno for renal care (kidney dialysis patients) and Albuzest-Hepa for hepatic and gastrointestinal care.

Brand names
AlbuzestAlbuzest-RenoAlbuzest-Hepa

Beyond the preview

Go deeper on Albuzest.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Albuzest.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call